,
your personalized virtual assistant to find clinical trials. Go head, 
Frederick M. Briccetti, MD
New Hampshire Oncology - Hematology, ...Concord, New Hampshire - 03301 (603-224-2556) |
- CLINICAL TRIALS 6
- CONDITIONS11
- INTERVENTIONS18
- SINCE2006
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer Metastatic Prostate Cancer or Multiple Myeloma With Bone Involvement
March 2009 - May 2015
Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
June 2008 - December 2009
Cisplatin Irinotecan and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
February 2006 - May 2007
Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer
November 2007 - November 2013
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
December 2006 - September 2011
Cisplatin or Carboplatin and Etoposide With or Without Sunitinib in Treating Patients With Extensive-Stage Small Cell Lung Cancer
March 2007 - November 2011
Breast Neoplasms
Lung Neoplasms
Prostatic Neoplasms
Multiple Myeloma
Neoplasms, Plasma Cell
Neoplasms
Neoplasm Metastasis
Carcinoma, Non-Small-Cell Lung
Esophageal Diseases
Esophageal Neoplasms
Carcinoma, Small Cell
Placebo
Zoledronic Acid
Paclitaxel
Carboplatin
Bevacizumab
Cisplatin
Docetaxel
Neoadjuvant Therapy
Cyclophosphamide
Radiation Therapy
Doxorubicin Hydrochloride
Etoposide
Sunitinib Malate
Goserelin
Leuprolide Acetate
Conventional Surgery
Irinotecan Hydrochloride
Ac Regimen
